Zobrazeno 1 - 10
of 377
pro vyhledávání: ''
Autor:
Tam N M Ngo, Jan Mazur, Eugene S. Chung, Huy Gia Vuong, Vien T. Truong, Vy T. Pham, Binh Q Truong, Quoc Bui, Cassady Palmer
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 24, Pp 8838-8845 (2021)
Cancer Medicine, Vol 10, Iss 24, Pp 8838-8845 (2021)
Background The survival outcome for primary cardiac malignant tumors (PMCTs) based on race has yet to be fully elucidated in previously published literature. This study aimed to address the general long‐term outcome and survival rate differences in
Autor:
David Liska, Smitha S. Krishnamurthi, Alok A. Khorana, Kanika G. Nair, Nataly Valeria Torrejon, Suneel Deepak Kamath, Katherine Tullio, Wei Wei
Publikováno v:
Cancer Medicine, Vol 10, Iss 21, Pp 7542-7550 (2021)
Cancer Medicine
Cancer Medicine
Background The incidence of colorectal cancer (CRC) in patients under age 50 is rising for unclear reasons. We examined the effects of socioeconomic factors on outcomes for patients with early‐onset CRC compared to late‐onset CRC. Methods Patient
Autor:
De Shen Wang, Long Bai, Han Zhou, Wan-Lan Huang, Ze-Yu Lin, Qin Chen, Yun-Le Wan, Yun-Xin Lu, Qi Meng, Chun-Ping Lin, Zhizhong Pan
Publikováno v:
Cancer Medicine, Vol 10, Iss 22, Pp 8005-8019 (2021)
Cancer Medicine
Cancer Medicine
Background The prognostic value of lactate dehydrogenase (LDH) in colorectal cancer patients has remained inconsistent between nonmetastatic and metastatic settings. So far, very few studies have included LDH in the prognostic analysis of curative‐
Publikováno v:
Cancer Medicine, Vol 10, Iss 16, Pp 5545-5556 (2021)
Cancer Medicine
Cancer Medicine
Epigenetic regulation is important for cancer tumor metastasis and progression, including lung and liver cancer. However, the mechanism of epigenetic regulation in liver cancer leaves much to be discussed. According to a previous study, p300/CBP‐as
Autor:
Mariko Tabata, Yutaka Enomoto, Yusuke Sato, Masahiro Hikatsu, Hideyo Miyazaki, Yukio Yamada, Taro Murata, Yasushi Kondo, Tohru Nakagawa, Taketo Kawai, Jimpei Miyakawa, Haruki Kume, Satoru Taguchi, Akihiko Matsumoto, Akihiro Naito, Hiroaki Nishimatsu, Tomoyuki Kaneko, Takumi Takeuchi, Yoshinori Tanaka, Motofumi Suzuki
Publikováno v:
Japanese Journal of Clinical Oncology. 51:1577-1586
Purpose Renal function is frequently impaired in the patients with upper tract urothelial carcinoma. We aimed to evaluate the impact of renal function and its change after surgery on survival rates in patients with upper tract urothelial carcinoma af
Autor:
F. Stephen Hodi, Lisa Magarace, Jason L. Weirather, Brian J. Quattrochi, Nancy Bailey, Rizwan Haq, Michael Manos, Lynette M. Sholl, Patrick A. Ott, Elizabeth I. Buchbinder, Ryan C. Brennick, Anita Giobbie-Hurder, Peter Bowling, Benjamin Izar
Publikováno v:
Cancer Medicine, Vol 10, Iss 8, Pp 2627-2635 (2021)
Cancer Medicine
Cancer Medicine
Mucosal melanoma is a rare form of melanoma which arises from melanocytes in the mucosal membranes and can be effectively treated with immune checkpoint blockade (ICB). However, response rates in mucosal melanoma are lower than those observed for cut
Autor:
Hayet Amalou, Michal Mauda-Havakuk, Nidhi Jain, Elliot Levy, Bradford J. Wood, Maureen Edgerly, Tito Fojo, Elizabeth Levin, Michael S. Hughes, Victoria L. Anderson, Jaydira Del Rivero, Venkatesh Krishnasamy, Paul Wakim
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 7, Pp 2259-2267 (2021)
Cancer Medicine, Vol 10, Iss 7, Pp 2259-2267 (2021)
Background To evaluate outcomes and survival rates in patients with metastatic adrenocortical carcinoma (ACC) who were treated with image‐guided locoregional treatments (IGLTs). Purpose To evaluate the overall survival (OS) and clinical impact of I
Autor:
Aliyah Pabani, Benjamin W. Ewanchuk, Tina Cheng, Siddhartha Goutam, Isabelle A. Vallerand, Daniel Y.C. Heng, Igor Stukalin, Daniel E. Meyers, Michael Sander, Don Morris
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 8, Pp 2618-2626 (2021)
Cancer Medicine, Vol 10, Iss 8, Pp 2618-2626 (2021)
Background Metastatic uveal melanoma (MUM) is associated with poor survival and inferior response to immune checkpoint inhibitor (ICI) therapy when compared with metastatic cutaneous melanoma. Currently, prognostic biomarkers are lacking to guide tre
Autor:
Masahide Takahashi, Nobuhiro Hanai, Hidenori Suzuki, Michi Sawabe, Eiichi Sasaki, Sumitaka Hagiwara, Shintaro Beppu, Daisuke Nishikawa, Yasuhisa Hasegawa, Hoshino Terada
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 4, Pp 1335-1346 (2021)
Cancer Medicine, Vol 10, Iss 4, Pp 1335-1346 (2021)
Background Various biomarkers are being developed for the early diagnosis of cancer and for predicting its prognosis. The aim of this study is to evaluate the diagnostic significance of serum CD109 in head and neck squamous cell carcinoma (HNSCC). Me
Publikováno v:
Cancer Medicine, Vol 10, Iss 3, Pp 923-932 (2021)
Cancer Medicine
Cancer Medicine
Immunocheckpoint inhibitors (ICIs) have become a standard pharmacological therapy in non‐small cell lung cancer (NSCLC). Because brain metastases (BMs) have historically been listed as exclusion criteria in previous clinical trials involving ICIs i